Active ingredientBelinostatCat. No. P-B018-001CAS 866323-14-0Family · Pharmaceutical analytical standards
Belinostat
An anticancer drug of the hydroxamic acid family that inhibits histone deacetylase (HDAC) enzymes. It was approved in the United States in 2014 for relapsed or refractory peripheral T-cell lymphoma. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?Histones are the proteins around which DNA is wound like thread on a spool: by blocking HDAC enzymes, belinostat loosens this winding and can switch back on genes that slow the growth of tumour cells.
Go to the active ingredient →Active ingredientBelinostatCat. No. P-B018-001CAS 866323-14-0
MetaboliteBelinostat GlucuronideCat. No. P-B018-002CAS 1486471-13-9
Isotopically labelledBelinostat Acid-d5Cat. No. P-B018-003CAS 2130853-04-0
Isotopically labelledBelinostat Amide-d5Cat. No. P-B018-004
Isotopically labelledBelinostat Impurity 1-d5Cat. No. P-B018-005CAS 2130853-01-7
Isotopically labelledBelinostat-d5Cat. No. P-B018-006CAS 2130852-65-0
Isotopically labelledBelinostat-d5 GlucuronideCat. No. P-B018-007
Isotopically labelledMethyl Belinostat-d5Cat. No. P-B018-008
ImpurityBelinostat 3-Anilinosulfonyl AnalogCat. No. P-B018-009CAS 1576-45-0
ImpurityBelinostat AcidCat. No. P-B018-010CAS 866323-87-7
ImpurityBelinostat AmideCat. No. P-B018-011CAS 1485081-57-9
ImpurityBelinostat Methyl ester ImpurityCat. No. P-B018-012CAS 866323-86-6
ImpurityBelinostat Z-isomerCat. No. P-B018-013CAS 1884227-58-0
ImpurityMethyl BelinostatCat. No. P-B018-014CAS 1485081-34-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.